Annex 21 – Are we on track and is there an impact?
Blog Post

Annex 21 – Are we on track and is there an impact?

Annex 21 went into effect on August 21, 2022. It’s time to check that processes and procedures have not fallen short of the actual requirements...

Read More
FDA Quality Management Maturity Program
Blog Post

FDA Quality Management Maturity Program

Drug shortages in the pharmaceutical industry is a significant concern that has far-reaching consequences for the industry, the regulators, the healthcare system, and ultimately the...

Read More
Bridging the Gap: Role Clarity, Skill Investment, and the Battle Against Drug Shortages 
Blog Post

Bridging the Gap: Role Clarity, Skill Investment, and the Battle Against Drug Shortages 

As advancements in medical science continue to expand the array of available treatments, the demand for pharmaceuticals has surged.  This surge has caused an alarming...

Read More
Solving Drug Shortages With AI
Blog Post

Solving Drug Shortages With AI

Explore the positive impact of artificial intelligence (AI) on pharmaceutical manufacturing, addressing persistent drug shortages. Dive into the benefits of predictive analytics, quality control enhancements,...

Read More